細胞シグナル伝達市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、製品別、技術別、経路別、地域別、競合市場別、2020～2030年

細胞シグナル伝達の世界市場は、2024年に56億2,000万米ドルと評価され、予測期間中のCAGRは7.87%で、2030年には88億7,000万米ドルに達すると予測されています。

細胞シグナル伝達の世界市場は、慢性疾患の増加、分子生物学の進歩、個別化医療に対する需要の高まりが主要要因となっています。細胞シグナル伝達は、成長、分化、免疫反応などの主要な細胞プロセスの制御において重要な役割を果たしており、特にがん、糖尿病、神経疾患などの疾病メカニズムにおいて不可欠なものとなっています。創薬の増加と標的治療の必要性は、細胞シグナル伝達経路が新しい治療標的を特定する上で極めて重要であることから、市場をさらに促進しています。高性能スクリーニング、バイオマーカー、診断ツールの技術的進歩が、細胞シグナル伝達調査の効率を高めています。医療やライフサイエンス研究への投資拡大も市場拡大に大きく貢献しています。

市場概要
予測期間	2026～2030年
市場規模：2024年	56億2,000万米ドル
市場規模：2030年	88億7,000万米ドル
CAGR：2025～2030年	7.87%
急成長セグメント	内分泌シグナル伝達
最大市場	北米

市場促進要因

慢性疾患とがんの有病率の増加

主要市場課題

細胞シグナル伝達経路の複雑さ

主要市場動向

バイオテクノロジーにおける公的・民間資金の増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の細胞シグナル伝達市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（内分泌シグナル伝達、傍分泌シグナル伝達、自己分泌シグナル伝達、その他）
  • 製品別（消耗品・器具）
  • 技術別（フローサイトメトリー、顕微鏡検査、ウェスタンブロッティング、ELISAなど）
  • 経路別（AKTシグナル伝達経路、AMPKシグナル伝達経路、ErbB/HERシグナル伝達経路など）
  • 地域別
  • 企業別（2024年）
• 市場マップ

第6章 北米の細胞シグナル伝達市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の細胞シグナル伝達市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋の細胞シグナル伝達市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の細胞シグナル伝達市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの細胞シグナル伝達市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収（該当する場合）
• 製品の発売（該当する場合）

第13章 ポーターのファイブフォース分析

• 産業内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Thermo Fisher Scientific, Inc.
• QIAGEN N.V.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• Cell Signaling Technology, Inc.
• Danaher Corporation
• Merck KGaA
• PerkinElmer, Inc.
• Promega Corporation

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Cell Signaling Market was valued at USD 5.62 Billion in 2024 and is expected to reach USD 8.87 Billion by 2030 with a CAGR of 7.87% during the forecast period. The Global Cell Signaling Market is primarily driven by the increasing prevalence of chronic diseases, advancements in molecular biology, and the growing demand for personalized medicine. Cell signaling plays a crucial role in regulating key cellular processes such as growth, differentiation, and immune response, making it vital in disease mechanisms, particularly cancer, diabetes, and neurological disorders. The rise in drug discovery and the need for targeted therapies are further propelling the market, as cell signaling pathways are pivotal in identifying new therapeutic targets. Technological advancements in high-throughput screening, biomarkers, and diagnostic tools are enhancing the efficiency of cell signaling research. Growing investments in healthcare and life sciences research also contribute significantly to market expansion.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 5.62 Billion
Market Size 2030	USD 8.87 Billion
CAGR 2025-2030	7.87%
Fastest Growing Segment	Endocrine Signaling
Largest Market	North America

Key Market Drivers

Increasing Prevalence of Chronic Diseases and Cancer

Chronic diseases, including cancer, cardiovascular diseases, diabetes, and neurological disorders, have become a major public health concern worldwide. Cancer alone has led to an exponential increase in demand for targeted therapies that specifically influence cell signaling pathways. Cell signaling mechanisms are crucial in both the initiation and progression of cancer. As cancer cells exploit these pathways to grow uncontrollably, therapies targeting these signaling mechanisms are rapidly being developed. According to WHO, in 2021, noncommunicable diseases (NCDs) were responsible for at least 43 million deaths, accounting for 75% of all non-pandemic-related deaths globally. Among these, 18 million individuals died from an NCD before reaching 70 years of age, with 82% of these premature deaths occurring in low- and middle-income countries. Overall, 73% of all NCD-related deaths took place in these regions. Cardiovascular diseases were the leading cause, responsible for at least 19 million deaths in 2021, followed by cancers (10 million), chronic respiratory diseases (4 million), and diabetes (over 2 million, including kidney disease deaths related to diabetes). Together, these four disease categories contribute to 80% of all premature NCD deaths. Risk factors such as tobacco use, physical inactivity, excessive alcohol consumption, unhealthy diets, and air pollution significantly increase the likelihood of dying from an NCD.

Key Market Challenges

Complexity of Cell Signaling Pathways

Cell signaling pathways are highly complex and involve numerous molecules, receptors, enzymes, and transcription factors that interact with each other in a precise and sometimes unpredictable manner. This complexity makes understanding the exact mechanisms behind cellular responses to stimuli challenging. Researchers are often confronted with difficulties in fully mapping out the networks of signaling pathways in different cell types and under varying physiological conditions. There is a lack of comprehensive tools and technologies capable of capturing all the intricacies of these networks. This complexity can delay the identification of key therapeutic targets and make drug discovery more difficult, particularly in diseases with dysregulated signaling. Targeting specific pathways without unintended consequences to other cellular processes is a major concern, increasing the risk of off-target effects. As a result, this complexity can slow the development of effective treatments based on cell signaling and hinder the overall market growth.

Key Market Trends

Increasing Public and Private Funding in Biotechnology

The biotechnology sector is witnessing a significant surge in public and private funding, which directly impacts the cell signaling market. Governments worldwide are investing in healthcare innovation through grants, subsidies, and tax incentives for biotechnology companies that focus on molecular and cellular therapies. Private sector investment, particularly from venture capital firms, is also growing as investors recognize the potential of cell signaling as a therapeutic target. These investments not only support basic research but also stimulate the development of new drug candidates, biologics, and diagnostic tools that leverage knowledge of cell signaling pathways. The increased funding enables the development of cutting-edge research centers and the commercialization of novel products, accelerating market growth.

Key Market Players

• Thermo Fisher Scientific, Inc.
• QIAGEN N.V.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• Cell Signaling Technology, Inc.
• Danaher Corporation
• Merck KGaA
• PerkinElmer, Inc.
• Promega Corporation

Report Scope:

In this report, the Global Cell Signaling Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Signaling Market, By Type:

• Endocrine Signaling
• Paracrine Signaling
• Autocrine Signaling
• Others

Cell Signaling Market, By Product:

• Consumables
• Instruments

Cell Signaling Market, By Technology:

• Flow Cytometry
• Microscopy
• Western Blotting
• ELISA
• Others

Cell Signaling Market, By Pathway:

• AKT Signaling Pathway
• AMPK Signaling Pathway
• ErbB/HER Signaling Pathway
• Others

Cell Signaling Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Signaling Market.

Available Customizations:

Global Cell Signaling market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Signaling Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, and Others)
  • 5.2.2. By Product (Consumables and Instruments)
  • 5.2.3. By Technology (Flow Cytometry, Microscopy, Western Blotting, ELISA, and Others)
  • 5.2.4. By Pathway (AKT Signaling Pathway, AMPK Signaling Pathway, ErbB/HER Signaling Pathway, and Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Cell Signaling Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Product
  • 6.2.3. By Technology
  • 6.2.4. By Pathway
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cell Signaling Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Technology
      • 6.3.1.2.4. By Pathway
  • 6.3.2. Canada Cell Signaling Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Technology
      • 6.3.2.2.4. By Pathway
  • 6.3.3. Mexico Cell Signaling Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Technology
      • 6.3.3.2.4. By Pathway

7. Europe Cell Signaling Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Product
  • 7.2.3. By Technology
  • 7.2.4. By Pathway
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cell Signaling Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Technology
      • 7.3.1.2.4. By Pathway
  • 7.3.2. United Kingdom Cell Signaling Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Technology
      • 7.3.2.2.4. By Pathway
  • 7.3.3. Italy Cell Signaling Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Technology
      • 7.3.3.2.4. By Pathway
  • 7.3.4. France Cell Signaling Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Technology
      • 7.3.4.2.4. By Pathway
  • 7.3.5. Spain Cell Signaling Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Technology
      • 7.3.5.2.4. By Pathway

8. Asia-Pacific Cell Signaling Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Product
  • 8.2.3. By Technology
  • 8.2.4. By Pathway
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cell Signaling Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Technology
      • 8.3.1.2.4. By Pathway
  • 8.3.2. India Cell Signaling Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Technology
      • 8.3.2.2.4. By Pathway
  • 8.3.3. Japan Cell Signaling Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Technology
      • 8.3.3.2.4. By Pathway
  • 8.3.4. South Korea Cell Signaling Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Technology
      • 8.3.4.2.4. By Pathway
  • 8.3.5. Australia Cell Signaling Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Technology
      • 8.3.5.2.4. By Pathway

9. South America Cell Signaling Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Product
  • 9.2.3. By Technology
  • 9.2.4. By Pathway
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cell Signaling Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Technology
      • 9.3.1.2.4. By Pathway
  • 9.3.2. Argentina Cell Signaling Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Technology
      • 9.3.2.2.4. By Pathway
  • 9.3.3. Colombia Cell Signaling Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Technology
      • 9.3.3.2.4. By Pathway

10. Middle East and Africa Cell Signaling Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Product
  • 10.2.3. By Technology
  • 10.2.4. By Pathway
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cell Signaling Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Technology
      • 10.3.1.2.4. By Pathway
  • 10.3.2. Saudi Arabia Cell Signaling Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Technology
      • 10.3.2.2.4. By Pathway
  • 10.3.3. UAE Cell Signaling Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Technology
      • 10.3.3.2.4. By Pathway

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. QIAGEN N.V.
• 14.3. Becton, Dickinson and Company
• 14.4. Bio-Rad Laboratories, Inc.
• 14.5. Bio-Techne Corporation
• 14.6. Cell Signaling Technology, Inc.
• 14.7. Danaher Corporation
• 14.8. Merck KGaA
• 14.9. PerkinElmer, Inc.
• 14.10. Promega Corporation

15. Strategic Recommendations

16. About Us & Disclaimer